Previous Post: Nick Buckles tells MPs G4S will claim its multi-million management fee despite Olympics ‘shambles’ nbsp
TPG to buy generic drugmaker Par for $1.9 billion
Reuters – Private equity firm TPG said on Monday it would acquire U.S.-based Par Pharmaceutical Cos Inc for $1.9 billion, the latest acquisition in the generic drug industry. The $50-a-share deal represents a nearly 37 percent premium over Par’s closing price on Friday. Read article
Tags: financial system, nature of corporations, pharmaceuticals
Related posts:
Bin Laden widow’s testimony shames slack Pakistan
Destroying Innocence: Sexualization of Children by HBO
U.S. Navy attack "threatens regional security": Iran foreign ministry
Pasok’s Venizelos in third bid for Greece coalition
Jack Harrison: Beyond Male and Female: Creativity, Risks, and Resilience Among Genderqueer People in...
5 Star Wars-Inspired Green(ish) Gadgets